Thomas Walley
Impact in
- Toxicology top 0.05%
- Pharmacovigilance and Adverse Drug Reactions
- Geriatrics and Gerontology top 0.2%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 7
- Pharmaceutical Economics and Policy 5
- Co-authors
- Munir Pirmohamed (3 shared papers)Alasdair Breckenridge (3 shared papers)B Kevin Park (2 shared papers)Chris Green (1 shared paper)Keith Farrar (1 shared paper)Andrew Scott (1 shared paper)Alan Haycox (2 shared papers)A Bagust (2 shared papers)
- Journals
- British Journal of Clinical Pharmacology (4 papers)Controlled Clinical Trials (1 paper)Health Policy and Planning (1 paper)PharmacoEconomics (1 paper)International Journal of Cardiology (1 paper)
- Partner nations
- United KingdomItalyNetherlands
In The Last Decade
Thomas Walley
23 papers receiving 2.4k citations
Thomas Walley's Hit Papers
Peers
Comparison fields: 5 of 126
- Toxicology 763
- Geriatrics and Gerontology 673
- Family Practice 72
- Pharmacology 349
- Pediatrics, Perinatology and Child Health 383
Countries citing papers authored by Thomas Walley
This map shows the geographic impact of Thomas Walley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Walley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Walley more than expected).
Fields of papers citing papers by Thomas Walley
This network shows the impact of papers produced by Thomas Walley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Walley. The network helps show where Thomas Walley may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Walley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients Hit paper breakdown → | 2004 | 2297 |
| 2 | 2003 | 77 | |
| 3 | 1999 | 52 | |
| 4 | 1997 | 28 | |
| 5 | 1991 | 24 | |
| 6 | 1997 | 14 | |
| 7 | 1999 | 12 | |
| 8 | Reporting of adverse drug reactions: practice in the UK. | 1998 | 9 |
| 9 | 2007 | 9 | |
| 10 | 2018 | 8 | |
| 11 | 2007 | 8 | |
| 12 | Auditing the management of hypertension in British general practice: a critical literature review. | 1998 | 8 |
| 13 | 2003 | 6 | |
| 14 | 2002 | 5 | |
| 15 | 1991 | 4 | |
| 16 | THE USE OF HEALTH ECONOMICS BY HOSPITAL PHARMACIST DECISION MAKERS : A SURVEY OF UK CHIEF PHARMACISTS | 1997 | 3 |
| 17 | 1994 | 3 | |
| 18 | 1993 | 3 | |
| 19 | 1992 | 3 | |
| 20 | 1996 | 2 |
About Thomas Walley
Thomas Walley is a scholar working on Economics and Econometrics, General Health Professions, Cardiology and Cardiovascular Medicine, Toxicology and Surgery, having authored 25 papers that have together received 2.6k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmaceutical Economics and Policy (5 papers), Pharmacovigilance and Adverse Drug Reactions (4 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Drug-Induced Adverse Reactions (3 papers), Patient Safety and Medication Errors (2 papers), Acute Myocardial Infarction Research (2 papers) and Clinical practice guidelines implementation (2 papers). The work is most often cited by research in Toxicology (763 citations), Geriatrics and Gerontology (673 citations), Family Practice (72 citations), Pharmacology (349 citations) and Pediatrics, Perinatology and Child Health (383 citations). Thomas Walley has collaborated with scholars based in United Kingdom, Italy and Netherlands. Frequent co-authors include Munir Pirmohamed, Alasdair Breckenridge, B Kevin Park, Chris Green, Keith Farrar, Andrew Scott, Alan Haycox, A Bagust, D. J. Webb and AM Breckenridge. Their work appears in journals such as British Journal of Clinical Pharmacology, Controlled Clinical Trials, Health Policy and Planning, PharmacoEconomics and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.